Boothbay Fund Management’s AstraZeneca AZN Stock Holding History

Boothbay Fund Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,950	Closed	-$4.73M	–	1649
2023 Q3	$4.73M	Sell	34,950 -338,750	-91%	-$46.3M	0.11%	230
2023 Q2	$53.5M	Buy	373,700 +302,350	+424%	+$44.5M	1.17%	4
2023 Q1	$9.9M	Buy	+71,350	New	+$9.6M	0.2%	79
2017 Q3	–	Sell	-21,250	Closed	-$1.45M	–	605
2017 Q2	$1.45M	Buy	+21,250	New	+$1.39M	0.3%	65

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boothbay Fund Management's AZN Position: Q2 2026 in Review

Boothbay Fund Management increased its AstraZeneca (AZN) stake by 1.1% in Q2 2026, buying an estimated $7.9K and bringing the position to 3,909 shares worth $741K. The position accounts for 0.01% of the portfolio, ranked #1276.

Boothbay Fund Management first reported a position in AZN in Q3 2019 and has held it in 18 quarters since. The position peaked at $10.2M in Q1 2021. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Boothbay Fund Management held 3,909 shares of AstraZeneca worth $741K as of Q2 2026.
Boothbay Fund Management bought 42 AstraZeneca shares in Q2 2026, an estimated $7.9K.
AstraZeneca made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1276 holding.
Boothbay Fund Management first reported a position in AstraZeneca in Q3 2019 and has held it in 18 quarters since.
Boothbay Fund Management's AstraZeneca position peaked at $10.2M in Q1 2021.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.